Observational cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitis and rapidly progressive glomerulonephritis
Not Applicable
- Conditions
- ANCA-associated vasculitis and rapidly progressive glomerulonephritis
- Registration Number
- JPRN-UMIN000005136
- Lead Sponsor
- Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan
- Brief Summary
The RPGN grading system was more useful to predict 6-month overall and ESRD-free survival than the EUVAS-defined severity or FFS 2009.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with relapse Malignancy Replicating hepatitis B and C
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method